Can Ethnicity Hold Clues to Side Effects in Young Leukemia Patients?

A multidisciplinary research team led by Song Yao, PhD, Professor of Oncology in the Department of Cancer Prevention and Control at Roswell Park Comprehensive Cancer Center and Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s Cancer and Blood Disorders Program, has received a critical grant

Read more

Fighting Cancer in Native and Rural Communities

Today, Roswell Park Comprehensive Cancer Center and the Bristol Myers Squibb Foundation announced a $3.3 million program to address the cancer burden in rural areas and Native Nations across New York State, with an emphasis on the Western New York region. The grant from the Bristol Myers

Read more

Roswell Park Expert Offers Insights on Multiple Myeloma

Roswell Park Comprehensive Cancer Center’s Chief of Myeloma, Jens Hillengass, MD, is slated to speak at the National Comprehensive Cancer Network (NCCN) 2020 Virtual Congress on Hematologic Malignancies, happening October 9 and 10. Dr. Hillengass, a member of the NCCN’s Guidelines Panel for Multiple Myeloma, will present on “Evolving Concepts

Read more

Roswell Park, Ellis Medicine Announce Partnership

Ellis Medicine and Roswell Park Comprehensive Cancer Center marked a major milestone today with the announcement of an affiliation that will bring new medical oncology services to Ellis Hospital. Ellis is creating a medical oncology/chemotherapy/infusion center at the hospital—and through the affiliation, will expand local access to

Read more

Influential Immunotherapy Organization at Roswell Park

Elected by a body of fellow immunotherapy researchers from across the globe, Roswell Park Comprehensive Cancer Center Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, has been named an At-Large Director for the Society for Immunotherapy of Cancer (SITC) Board of Directors. The nonprofit organization’s members voted

Read more

Roswell: New Strategy for Treating Pancreatic Cancer

Roswell Park Team Proposes Strategy for Making Pancreatic Tumors Respond to Checkpoint Inhibition New study provides rationale for combining targeted therapies with anti-PD-L1 immunotherapy Most pancreatic cancers do not respond to immune checkpoint inhibitors In lab, combination of CDK4/6 inhibitors and MEK inhibitors slowed tumor growth Targeted

Read more

Roswell Park Team Discovers New Mechanism Driving Pancreatic Cancer

Length of some regions of messenger RNA plays key role in regulating gene expression, cancer growth Role revealed for little-known process known as alternative polyadenylation First large-scale single-cancer analysis of alternative polyadenylation events Changes to length of certain RNA segments can be key prognostic indicator  BUFFALO, N.Y.—

Read more

Roswell Park Employees Show Support for Local Cancer Patients

Roswell Park Comprehensive Cancer Center employees and their family members will show their support for cancer patients by participating in the Goin’ Bald for Bucks program, which raises funds for cancer research and patient-care programs at Roswell Park. More than 30 Roswell Park employees have grown out

Read more

How Stress Weakens Immunity Against Cancer

Roswell Park Team Helps Explain How Chronic Stress Weakens Immunity Against Cancer Researchers identify new mechanism associated with aggressive growth in cancer tumors Team found chronic stress can increase MSDC cells, leading to tumor growth One of the first studies to explain the impacts of stress on

Read more